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DERIVATIVES OF N-CHLORO-N-METHYL
GLUCAMINE AND N-CHLORO-N-METHYL
GLUCAMINE ESTERS

a poWerful germicidal agent. The compounds of the present
invention have the folloWing structure:

This application is a divisional of application Ser. No.
08/736,913, ?led Oct. 25, 1996 now US. Pat. No. 5,753,
701.
BACKGROUND OF THE INVENTION

1. Field of the Invention

10

The present invention relates to N-chloro-N-methyl glu
camine and N-chloro-N-methyl glucamine esters, and their
use as agents for Water disinfection and as mild oxidizing

agents for the radiolabeling of oxidation-sensitive organic

15

molecules.
2. Description of the Related Art
Chloramines are Widely knoWn as useful Water disinfect

procedures involving oxidation-sensitive organic molecules

ing agents. Among the most popular chloramine Water

disinfecting agents is halaZone (p-N,N
dichlorosulfamylbenZoic acid). While effective, halaZone
suffers from some important disadvantages, including its
strong, unpleasant chlorine odor, its sensitivity to light, its
relatively loW solubility in Water, and, perhaps most
importantly, the formation of potentially carcinogenic chlo

20

25

rinated hydrocarbons Which are generated as the result

and similar substrates. The present inventors have observed
that the N-chloro derivatives of secondary amines, such as
N-methyl glucamine and its esters, are much Weaker oxi
diZing agents than N-chloro compounds, such as
chloramine-T and halaZone. When used in radiohalogena
tion procedures, N-chloro secondary amines do not oxidiZe
most organic molecules.

With the foregoing and other objects, advantages and

reaction With impurities commonly found in Water supplies.
In vieW of these disadvantages, it should be apparent that

features of the invention that Will become hereinafter
apparent, the nature of the invention may be more clearly

there still exists a need in the art for improved Water

disinfecting agents.

Wherein R is —H or —COR2, Wherein R2 is loWer alkyl.
These compounds are useful as disinfecting agents, particu
larly for disinfecting Water supplies. When used as a
disinfectant, the compounds of the present invention gener
ate N-methyl glucamine, a very safe agent, in parts per
millions.
A further object of the present invention is to meet the
need for a mild oxidiZing agent for use in radiohalogenation

30

understood by reference to the folloWing detailed descrip
tion of the preferred embodiments of the invention and to the

Chloramines, in particular chloramine-T (CAT) are fre

appended claims.

quently used in the radiolabeling of organic molecules by
halogenation, for example, as described in US. Pat. No.
5,424,402 (“the ’402 patent”), the contents of Which are
incorporated herein by reference. According to the method
of the ’402 patent an organic molecule may be radiolabeled

BRIEF DESCRIPTION OF THE DRAWINGS
35

FIG. 1: UV absorbance spectra of NaOCl (1), penta-O

acetyl-N-chloro-N-methylglucamine (NCMG)(2), and

by reaction With 12512. Normally, the 12512 is released from
its sodium salt by oxidation With chloramine-T. The disad
vantage of this procedure is that residual CAT in the reaction
mixture frequently causes oxidative decomposition of the

penta-O-acetyl-N-methylglucamine (NMG)(3).
FIG. 2: Fraction of L-tyrosine (Tyr), mono-3-iodo-L
40

for four methods of iodinating L-tyrosine in phosphate

organic molecule rendering the procedure useless. There

buffer (0.01M, pH 7.2).

exists a need for a mild oxidiZing agent that is capable of

releasing molecular halogens from their salts Without oxi
diZing organic molecules to be labeled.

FIG. 3: Peak areas of leucine enkephalin (Leu-Enk),
45

N-methyl glucamine is knoWn in the prior art as a

solubiliZing agent in the formulation of intravenous

pharmaceuticals, enabling high concentrations of pharma
ceuticals to be administered. HoWever, prior to the present
invention the particular substituted glucamines of the
present invention, and their use in the puri?cation of Water,

FIG. 4: Susceptibility of L. pneumophila AA100 to dif
50

FIG. 5: Kinetics of killing of L. pneumophila by 105 ppm
NCMGE.

FIG. 6: Susceptibility of L. pneumophila AA100 in

SUMMARY OF THE INVENTION
55

Accordingly, a major object of the present invention is to
meet the art-recogniZed need for a safe, effective and inex

these compounds satisfy the need for an agent that can be
conveniently used in households to disinfect Water, espe
cially in developing nations, as a replacement for HalaZone.
The present inventors have found that chlorination of

N-methyl glucamine yields N-chloro-N-methyl glucamine,

iodoleucine enkephalin Iodo-Leu-Lek), and diiodoleucine
enkephalin (Diiodo-Leu-Enk) for six methods of iodinated
leucine enkephalin in phosphate buffer.
ferent NCMGE concentrations.

Was not knoWn.

pensive method for disinfection of Water supplies.
Advantageously, the compounds of the present invention
minimiZe the formation of the carcinogenic chlorinated
hydrocarbons Which are currently generated as the result of
disinfection With halaZone and similar agents. Furthermore,

tyrosine (Iodo-Tyr), and 3,5-diiodo-L-tyrosine (Diiodo-Tyr)

co-culture With H. vermiformis to 105 ppm NCMGE in 30
minutes incubation.

FIG. 7. Kinetics of multiplication of L. pneumophila
AA100 Within H. vermiformis.
60

DETAILED DESCRIPTION OF THE
PREFERRED EMBODIMENTS OF THE
INVENTION

The present inventors have found that chlorination of
65

N-methyl glucamine yields N-chloro-N-methyl glucamine,
a poWerful germicidal agent. The compounds of the present
invention comprise the folloWing structure:

5,985,239
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(a) reacting a compound according to the present inven
tion With a radiolabeled halide salt and an organic
molecule Which is desired to be radiolabeled such that

said radiolabeled halogen reacts directly With said
organic molecule to produce a radiohalogenated
wherein R is —H or —COR2, wherein R2 is loWer alkyl.
These compounds are useful as disinfecting agents, particu
larly for disinfecting Water supplies. When used as a
disinfectant, the compounds of the present invention gener
ate N-methyl glucamine, a very safe agent, in parts per
millions.

organic molecule; and
(b) recovering said radiohalogenated organic molecule.
The method of the present invention may advantageously be
10

The compounds of the present invention are also useful as

mild oxidiZing agents for use in radiohalogenation proce

dures involving oxidation-sensitive organic molecules, in

15

radiolabeled halogen; then, the organic compound to be
labeled is added to the mixture.

For use in the present invention, the radiolabeled halogen
salt is preferably selected from the group consisting of

sodium, potassium, lithium, rubidium, cesium, magnesium,
20

calcium, and ammonium salts. Particularly preferred are
sodium halogen salts, most preferably sodium iodide.
The folloWing examples are presented in order to more

fully illustrate the preferred embodiments of the invention.
They should in no Way be construed, hoWever, as limiting

The compounds of the present invention may be synthe
siZed by any means knoWn to the skilled artisan. Preferably,
the compounds of the present invention are prepared from
N-methylglucamine, Which may be obtained commercially

embodiment, the method of the present invention provides
that the compound according to the present invention and
the radiolabeled halide salt are mixed together ?rst, such that
the radiolabeled halide salt is converted into molecular

particular oxidation-sensitive biomolecules and similar sub
strates. The present inventors have observed that the
N-chloro derivatives of secondary amines, such as N-methyl
glucamine and its esters, are much Weaker oxidiZing agents
than N-chloro compounds, such as chloramine-T and hala
Zone. When used in radiohalogenation procedures, N-chloro
secondary amines do not oxidiZe most biomolecules.

carried out in the presence of a buffer. In a preferred

25

the broad scope of the invention.

or may be synthesiZed according to any method knoWn to

EXAMPLE 1

the skilled artisan. For example, N-methylglucamine may be

synthesiZes from D-glucose and methylamine according to
the method of Karrer (Helv. Chim. Acta 20:83 (1937), the
contents of Which are incorporated herein by reference).
The present invention also provides compositions of

Preparation of Penta-O-Acetyl-N-Chloro-N
30

(NMGE):

matter comprising one or more of the compounds of the
present invention and a suitable carrier therefor. These

compositions may also include other disinfectant

Methylglucamine (NCMGE)
a. Synthesis of Penta-O-Acetyl-N-Methylglucamine

CHZb

35

compounds, including chlorinating compounds such as
halaZone, or other antibiotic agents. Compositions according

NHZh

to the present invention may be formulated in any manner
suitable for use as a disinfectant. For example, compositions
of the present invention may be provided as aqueous solu

40

tions or suspensions. More preferably, the compositions of
the present invention are provided in solid form. Particularly
preferred are tablet and granular forms of the composition of
the present invention, Which provide for easy storage and
handling. Tablets and granules may be formulated according

45

c104

CH2c
O

H°—C—O—C—CH3“

to any means knoWn in the art. For the purposes of the

present invention tablets may be of any convenient siZe;
granules are small grains of the composition of the present
invention; preferably, said grains are betWeen tWo and four
millimeters in diameter.
The present invention also provides a method of disin

dH2c—o—c—cH3a
50

Penta-O-Acetyl-N-Met_hylglucan1ine Perchlorate

fecting Water comprising adding the compounds or compo

N-methylglucamine(10 g) Was dissolved in 7.4 g (4.4 ml)

sitions of the present invention in an amount suf?cient to
disinfect the Water. For the purposes of the present

invention, disinfection encompasses killing bacteria and
protoZoans living in the Water to be disinfected. Preferably,
the compounds or compositions of the present invention Will

of (70%) perchloric acid in a round bottom ?ask. Ethyl
55

be added to the Water to be disinfected such that the ?nal

Washed With ether and recrystalliZed from acetone/

concentration of the compounds of the present invention in
the Water Will be at least 10 parts per million (ppm), more

60

preferably from 60—200 ppm, most preferably 105 ppm.
The present invention also provides a method for non

destructively radiolabeling biomolecules by halogenation.
The method of the present invention is advantageously

applied to radiolabeling of oxidation-sensitive organic
molecules, particularly oxidation-sensitive biomolecules.
The method of the present invention comprises

acetate (500 ml) Was added. The solution Was stirred, and 73
g of acetyl chloride Was added dropWise. The solution Was
left stirring at room temperature for four days until a White
solid Was formed. The resulting White solid Was ?ltered and

65

petroleum ether mixture and dried overnight in a vacuum
oven. The melting point of the solid Was 148—150° C.; MW

504.45; 1H-NMR (DMSO-d?) (FIG. 1): 62.05 (15H, m,
protons a), 2.56 (3H, S, protons b), 3.13 (2H, m, protons c),
4.20 (2H, m, protons d), 4.98 (1H, proton e), 5.05 (1H, m,
proton f, 5.27 (2H, protons g), 8.47 (2H, broad s, protons h).
b. Synthesis of Penta-O-Acetyl-N-Chloro-N

Methylglucamine (NCMGE):

5,985,239
6

5

equal volume of 1-aminocyclohexanecarboxylic acid
(0.02M), (t=0). The mixture Was stored at 25° C. and

assayed periodically by titration, as described above. A
CH;

control experiment Was conducted in the absence of the
amino acid.

0

2. Iodination of L-tyrosine
Solutions:

Phosphate buffer (0.01M, pH 7.4): A total of 5.0 g of
O

H

10

NaCl, 0.1 g KCI, 0.57 g Na2HPO4, and 0.1 g KHZPO4 Were
dissolved in 500 ml of glass distilled Water. The pH of the
solution Was adjusted to 7.4 With either NaOH or HCl, as

15

needed.
L-tyrosine solution: A total of 25 mg of L-tyrosine Was
dissolved in 100 ml of phosphate buffer.
Sodium Iodide solution: A total of 207 mg of sodium
iodide Was dissolved in 100 ml phosphate buffer.

Penta-O-acetyl-N-chloro-N-methylglucamine solution
(NCMGE): A total of 141 mg of NCMGE Was dissolved in

100 ml of phosphate buffer (0.01M, pH 7.4).
Penta-O-acetyl-N-methylglucamine (3.0 g) Was dissolved

20

Experimental:

The HPLC system for analysis Was as folloWs:
addition of 2N NaOH solution. Chlorine gas Was bubbled
Mobile phase=Distilled Water/methanol/85% phosphoric
into the solution for a feW minutes until a White solid Was
acid=(550/450/8).
formed. The solid Was ?ltered and Washed With Water and
FloW rate=1.0 ml/min.
dried in a vacuum oven. The melting point Was 77—79° C.; 25 Detector UV Wavelength 254 nm

in Water and the pH of the solution Was adjusted 6.0 by

Temperature=ambient.

MW 439.45; 1H-NMR (CDCl3): 62.08 (15H, m, protons a),
2.93 (3H, S, protons b), 3.05 (2H, m, protons c), 4.20 (2H,
m, protons d), 5. 10 (IH, proton e), 5.40 (IH, m, proton f),

Method I: A total of 0.2 ml of L-tyrosine solution, 0.02 ml
sodium iodide solution, and 0.108 ml of phosphate buffer

5.44 (2H, protons g).

Were mixed in a tube for tWo minutes, then 0.172 ml of

Elemental analysis: Found: C,46.24; H, 5.9 1; N, 3.17; Cl,
8.15%. Calculated for C17H26O1ONCl: C, 46.41; H, 5.9 1; N,
3.18; Cl, 8.08%.
The product Was also identi?ed by UV spectrophotometry

30

NCMGE solution Was added (t=0), and 50 pl samples Were
WithdraWn at 2 and 15 minutes and injected directly into the
HPLC.

Method II: A total of 0.2 ml of L-tyrosine solution, and

(FIG. 1).

0.02 ml of sodium iodide solution Were mixed in a tube for

EXAMPLE 2

35

injected directly into the HPLC.

The Use of NCMGE in Radiolabeling Techniques

3. Iodination of leucine enkephalin

1. Chemical Stability of a Model Amino Acid

(1-Aminocyclo-hexane Carboxylic Acid) in the Presence of
Chloramine-T, NCMG, and NCMGE.

2 minutes, then 0.780 ml of NCMGE solution Was added,
and 50 pl samples Were WithdraWn at 2 and 15 minutes and

Solutions:
40

N-chloro amino acids, such as N-chloro-l-amino

Phosphate buffer (0.01M, pH 7.4), sodium iodide
solution, and NCMGE solution Were the same as those for

cyclohexane carboxylic acid, Which are formed by chlori

the iodination of tyrosine.

nation of the amine group, are very unstable (Hussain et al.
1995 Analyt. Biochem 224:221—226; AWad et al. 1990 J.
Pharm Sci. 79:1121—1122; the contents of both of these

Leucine enkephalin solution: A total of 8.9 mg of leucine
enkephalin Was dissolved in 10 ml of phosphate buffer

articles are incorporated herein by reference). Their decom

(0.01M, pH 7.4).
Experimental:

positions are associated With loss of chlorine titer. In order
to determine Whether NCMG and NCMGE chlorinate

The HPLC system for analysis Was described above
(Section 2). The conditions Were the same as those described

45

1-aminocyclohexanecarboxylic acid, iodometric titration
Was used to folloW the reaction.

50

A solution of 1-aminocyclohexanecarboxylic acid con

the detector UV Wavelength Was set at 270 nm.

taining 2><10_3M Was prepared in 0.1M phosphate buffer
(pH 7.0) and equilibrated for 2 minutes at 25° C. For the
Chloramine-T (CAT) experiments, a solution of CAT

(1><10_3 M) in Water Was freshly prepared and equilibrated

Method I: A total of 0.2 ml of leucine enkephalin, 0.020
ml sodium iodide solution, and 0.083 ml of phosphate buffer
55

Was added and 50 pl samples Were WithdraWn and injected
directly into the HPLC. The addition of sodium thiosulfate

the mixture (4.0 ml) Were assayed periodically using stan

Was found necessary to decompose the residual NCMGE

dard iodometric titration; i.e. addition of excess KI and back
60

because NCMGE interfered With the enkephalin peaks in the
HPLC.

starch as an indicator. A control experiment Was carried out

by folloWing the chlorine titer of a solution of CAT in
phosphate buffer in the absence of the amino acid.
For the experiments With NCMG and NCMGE, a solution
of either NCMG or NCMGE (1><10_3M) in phosphate buffer

Were mixed in a tube for 2 minutes, then 0.172 ml of
NCMGE solution Was added (t=0). At the end of the reaction

(2 and 15 minutes), 25 pl of 20% sodium thiosulfate solution

for 2 minutes at 25° C. Equal volumes (10.0 ml) of the tWo
solutions Were mixed (t=0) and stored at 25° C. Aliquots of
titration of the liberated iodine With sodium thiosulfate using

above for the analysis of iodinated tyrosine products, except
the mobile phase Was (0.1M NaH2PO4/Methanol=1/1) and

Method II: A total of 0.2 ml of leucine enkephalin and
0.020 ml sodium iodide Were mixed in a tube for 2 minutes
65

and NCMGE solution (0.755 ml) Was added (t=0). At the
end of the reaction (2 and 15 minutes), 25 pl of 20% sodium

(0.1M, pH 7.0) Was freshly prepared and equilibrated for 2

thiosulfate solution Was added and 50 pl samples Were

minutes at 25° C., and a 10.0 ml aliquot Was mixed With an

WithdraWn and injected directly into the HPLC.

5,985,239
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4. Iodination of L-tyrosine
To determine Whether NCMGE Would have practical

B. Coincubation of Hartmannella vermiformis and

Legionella pneumophila.

activity in the radiohalogenation of amino acid, L-tyrosine,

Amoebae H. vermiformis Were suspended in assay
medium to give a ?nal concentration of 105 cell per ml.
Tissue culture ?asks containing amoebae Were inoculated

Was selected as a model and compared With the method

employed by Hussain et. al (1995 Analyt. Biochem
224:221—226), the contents of Which are incorporated herein
by reference. The results in FIG. 2 shoW that When NCMGE
Was used, the yield of the tWo iodinated species of
L-tyrosine Were signi?cantly greater With both 2 and 15
minutes incubation times than those obtained With CAT and
iodobead and close to that of N-chloromorpholine.
5. Iodination of leucine enkephalin
To determine Whether NCMGE Would have practical

With Legionella pneumophila, suspended in Pucks’ saline to
give a ?nal concentration of 103 bacteria per ml, and
incubated at 37° C. 1.2 ml aliquots Were WithdraWn imme

diately and 1, 2, 3, 5, and 7 days after inoculation. Of the 1.2
10

folloW the increase in the number of bacteria. The remaining

utility in radiohalogenation of small peptide, leucine
enkephalin Was selected as a model substrate for comparison 15

of iodination procedures employing CAT solution and
NCMGE. The methods Were tested using 2 and 15 minute
incubation times. The results in FIG. 3 shoW that When
NCMGE Was used, the yield of the tWo iodinated leucine

enkephalin species Were signi?cantly greater With both 2

20

The antimicrobial activity of N-chloramine penta-O
acetyl-N-chloro-N-methylglucamine (NCMGE) Was exam
25

30

incubation times. After each time interval, the chlorine
activity of NCMGE Was quenched by 0.01M sodium
35

Legionella pneumophila strain AA100 Was inoculated

into buffered charcoal-yeast extract (BCYE) agar plates and
incubated for 48 hours at 37° C. The bacteria Were sus

bisul?te. The results in FIG. 5 indicate that the shortest time
for Which groWth of L. pneumophila is not observed Was
found to be 20 minutes.

The antimicrobial activity of NCMGE (105 ppm) Was

pended into 0.01M phosphate buffer pH 7.4 to an optical
40

15 pl of bacterial suspension Was mixed With 7.0 ml

0.01M phosphate buffer (pH 7.4) containing disinfectant
compounds as listed in Table I. The concentration of bacteria
in this suspension Was approximately 1 million bacteria/ml.
After 30 minutes the activity of the disinfectant compounds

is based on incubation of the organism for 30 minutes at
different NCMGE concentrations. The results shoWn in FIG.
4 indicate that the MIC for NCMGE is 105 ppm. Second the
antimicrobial activity Was examined using the contact ger

micidal efficiency (CGE). This method involves examining
the bactericidal activity of NCMGE (105 ppm) at different

The antimicrobial activity of NCMGE Was examined in

density of 0.7—0.8 at 550 nm.

ined against Legionella pneumophila ?rst using the mini
mum inhibitory concentration (MIC) method. This method

N-methylglucamine (NCMGE)
the folloWing experiments:
A. Legionella pneumophila

three days. At the end of the three day period, the colony
forming units Were enumerated.
Results:

EXAMPLE 3

The germicidal activity of Penta-O-acetyl-N-chloro

1.0 ml Was centrifuged at 8000 rpm for 5 minutes. The
bacterial pellet Was Washed tWice With sterile deioniZed
Water. The pellet Was then suspended in 1.0 ml to 105 ppm
NCMGE solution for 30 minutes. After 30 minutes, tWo 20
pl aliquots of this NCMGE solution Were diluted in 0.01M
phosphate buffer to an approximate bacterial concentration

of 103 and 102/100 pl. 100 pl of these tWo dilutions Were
deposited on BCYE agar plates and incubated at 37° C. for

and 15 minutes incubation times. When CAT Was used alone

With a 15 minutes incubation time, the yield of the apparent
diiodinated species (labeled diiodo leuenk in FIG. 3) Was
signi?cantly smaller than When NCMGE Was present. This
appears to be the result of decomposition of leucine
enkephalin, as indicated by the smaller amount of all species
folloWing 15 minutes exposure to CAT alone (see FIG. 3).

ml, 0.2 ml Was cultured on BCYE agar plates in order to

also examined against a serogroups of L. pneumophila
compared to a control of 1000 cfu and incubation time of 30
minutes. The results shoWn in Table II shoW that this
NCMGE concentration kills all the strains of Legionella to
Which it Was exposed.
TABLE II

45

Was quenched With 0.4 ml 0.01M sodium bisul?te.
Susceptibility of L. pneumophila serogroups to 105 ppm NCMGE
compared to a control of 1000 cfu and incubation time of 30 minutes

TABLE 1
Names and concentrations of N-chloro compounds used in germicidal

experiment.
Compound
Control

Serogroup
50

Concentration
0

Monochloramine (NHZCI)
Penta-O-acetyl-N-chloro-N-methylglucamine
Penta-O-acetyl-N-chloro-N-methylglucamine

10
30
60

Penta-O-acetyl-N-chloro-N-methylglucamine

105

TWo aliquots of 20 pl of the ?nal solution of each of the
above Was diluted in 0.01M phosphate buffer to approximate
bacterial concentrations of 103 and 102/100 pl. 100 pl of the

55

60

% Survival

Philadelphia 1
Togus 1
Bloomington 2
Los Angeles 1

0
0
0
0

5

Dallas 1

0

6
7

Chicago 2
Chicago 8

0
0

8
9
10
11
12
13

Concord 3
IN 23
Leiden 1
797-PA-H
570-Co-H
82A3105

0
0
0
0
0
0

3The serogroups of L. pneumophila are distinguished by their lipopolysac

tWo ?nal dilutions Were groWn on BCYE agar plates that
Were incubated at 37° C. for three days. At the end of the

charide antigen.

three day incubation period, the colony forming unit Was
enumerated. Another experiment Was conducted against the
serogroups of Legionella pneumophila us ing NCMGE in a
concentration of 105 ppm.

13
2
3
4

Strain

Finally, the antimicrobial activity of NCMGE (105 ppm)
65

Was tested against a coculture of Legionella pneumophila

and H. vermiformis in Which the L. pneumophila typically
become more resistant to chlorine. The results shoWn that

5,985,239
9

10

NCMGE (105ppm) killed 95% of the bacteria at day 4 (FIG.
6), the time at which L. pneumophila typically reach their
maximum growth (as shown in FIG. 7). The results in FIG.

wherein R is —H or COR2, and wherein R2 is lower alkyl,
wherein that said radiolabeled halogen reacts directly with

said organic molecule to produce a radiohalogenated organic
molecule; and

6 also demonstrate that NCMGE has a powerful sustained

antimicrobial activity.

(b) recovering said radiohalogenated organic molecule.

While the invention has been described and illustrated

2. The method of claim 1, wherein said radiolabeled

herein by references to various speci?c material, procedures
and examples, it is understood that the invention is not
restricted to the particular material, combinations of
material, and procedures selected for that purpose. Numer

halogen salt is selected from the group consisting of sodium,

potassium, lithium, rubidium, cesium, magnesium, calcium,
10

ous variations of such details can be implied and will be

appreciated by those skilled in the art.
What is claimed is:

1. A method of labeling organic molecules comprising
(a) reacting an organic molecule with a radiolabeled
halide salt and a substituted N-chloro-N-methyl glu

camine compound comprising the following structure:
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and ammonium halide salts and mixtures thereof.
3. The method of claim 2, wherein said radiolabeled
halogen salt is a radiolabeled sodium halogen salt.
4. The method of claim 3, wherein said radiolabeled
sodium halogen salt is radiolabeled sodium iodide.
5. The method of claim 1, wherein said reaction takes
place in the presence of a buffer.

6. The method of claim 1, wherein said organic molecule
is a biomolecule.

7. The method of claim 1, wherein the substituted

N-chloro-N-methyl glucamine compound is miXed with the
radiolabeled halogen salt prior to miXing with the organic
compound to be labeled.
*

*

*

*

*

